<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02967549</url>
  </required_header>
  <id_info>
    <org_study_id>KCH16-150</org_study_id>
    <nct_id>NCT02967549</nct_id>
  </id_info>
  <brief_title>Neurally Adjusted Ventilatory Assist vs Proportional Assist Ventilation</brief_title>
  <official_title>Optimisation of Neonatal Ventilation - NAVA vs PAV</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King's College Hospital NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>King's College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to assess whether neurally adjusted ventilatory assist or proportional assist&#xD;
      ventilation is more effective in infants born prematurely with evolving or established&#xD;
      bronchopulmonary dysplasia&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite improvements in survival rates of extremely preterm born infants, the incidence of&#xD;
      bronchopulmonary dysplasia (BPD) remains unchanged over the last two decades. As invasive&#xD;
      ventilation is frequently necessary and indeed life saving, numerous ventilator strategies&#xD;
      have been developed to reduce damage to the developing lung. Synchronisation of mechanical&#xD;
      breaths with the patient's respiratory effort offers the theoretical benefit of improving&#xD;
      oxygenation and ventilation, requiring lower ventilator pressures, fewer air leaks and&#xD;
      increased patient comfort.&#xD;
&#xD;
      Recently, novel modes of ventilation have been introduced that aim to improve upon&#xD;
      conventional ventilation. During both proportional assist ventilation (PAV) and&#xD;
      neurally-adjusted ventilatory assist (NAVA), respiratory support is servo-controlled based on&#xD;
      continuous input from the baby's respiratory effort. Both aim to improve synchronization of&#xD;
      the timing of the respiratory cycle and also to vary the level of support offered&#xD;
      breath-to-breath in proportion to the respiratory effort of the patient.&#xD;
&#xD;
      During proportional assist ventilation (PAV), the ventilator can vary inflation pressure in&#xD;
      phase with both volume change and flow change in order to offload both elastic and resistive&#xD;
      components of the work of breathing. We have previously shown that PAV, compared to ACV,&#xD;
      reduces the oxygenation index and improves respiratory muscle strength in infants born&#xD;
      prematurely who remain ventilated at or beyond one week of life .&#xD;
&#xD;
      Neurally adjusted ventilatory assist (NAVA) utilises the electrical activity of the diaphragm&#xD;
      to trigger the ventilator. A modified nasogastric feeding tube with a series of electrodes&#xD;
      allows monitoring of the diaphragmatic electromyogram (Edi). The waveform of the Edi is used&#xD;
      to trigger and control ventilator support. We have recently shown that NAVA compared to ACV&#xD;
      results in a lower oxygenation index in infants born prematurely who remain ventilated at or&#xD;
      beyond one week of life.&#xD;
&#xD;
      Both PAV and NAVA have been shown to have advantages above conventional triggered ventilation&#xD;
      in neonates, but they have not been compared to each other. Our aim is to determine whether&#xD;
      NAVA or PAV is more effective in prematurely born neonates with evolving or established BPD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Actual">August 2018</completion_date>
  <primary_completion_date type="Actual">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxygenation index</measure>
    <time_frame>2 hours</time_frame>
    <description>Oxygenation index at the end of each period of ventilation</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Bronchopulmonary Dysplasia</condition>
  <arm_group>
    <arm_group_label>NAVA then PAV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infants randomised to NAVA then PAV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PAV then NAVA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infants randomised to PAV then NAVA</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NAVA</intervention_name>
    <description>NAVA delivered by the Servo-n ventilator (Maquet)</description>
    <arm_group_label>NAVA then PAV</arm_group_label>
    <arm_group_label>PAV then NAVA</arm_group_label>
    <other_name>neurally adjusted ventilatory assist</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PAV</intervention_name>
    <description>PAV delivered by the Stephanie ventilator (Stephan)</description>
    <arm_group_label>NAVA then PAV</arm_group_label>
    <arm_group_label>PAV then NAVA</arm_group_label>
    <other_name>Proportional Assist Ventilation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Born at less than 32 weeks gestation&#xD;
&#xD;
          -  ventilated at or beyond one week of life&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  major congenital abnormalities&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Year</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Greenough, MD, FRCPCH</last_name>
    <role>Study Director</role>
    <affiliation>King's College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Hunt KA, Dassios T, Greenough A. Proportional assist ventilation (PAV) versus neurally adjusted ventilator assist (NAVA): effect on oxygenation in infants with evolving or established bronchopulmonary dysplasia. Eur J Pediatr. 2020 Jun;179(6):901-908. doi: 10.1007/s00431-020-03584-w. Epub 2020 Jan 25.</citation>
    <PMID>31980954</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <study_first_submitted>November 15, 2016</study_first_submitted>
  <study_first_submitted_qc>November 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2016</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchopulmonary Dysplasia</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 28, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/49/NCT02967549/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

